Abstract
Using non-invasive anterior chamber fluorophotometry, we performed a double-blind, randomized clinical trial on the effects of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after phacoemulsification and posterior chamber lens implantation. Twenty patients received one of the preparations topically to the surgically treated eye 5 times daily for a period of 5 days, beginning the day after surgery. Patients chosen for the study had no history of eye disease other than senile cataract nor of systemic diseases influencing the eyes. No other steroids or non-steroidal anti-inflammatory drugs were given before or during the investigation. The fluorometric data measured 5 days after surgery show a lower mean concentration of fluorescein in the dexamethasone alcohol 0.1% treated group compared with the prednisolone acetate 1.0% treated group. The difference is statistically not significant. The clinical assessment of postoperative ocular inflammation did correlate with the fluorophotometric measurements. The results of the study indicate that although dexamethasone is the more potent anti-inflammatory agent, with a better binding affinity to glucocorticoid receptors, we are — with the number of cases measured — unable to demonstrate any difference in the efficacy in protecting the blood-aqueous barrier after cataract extraction and posterior chamber lens implantation to prednisolone acetate.
Similar content being viewed by others
References
Akingbehin AO (1983) Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%. Br J Ophthalmol 67:661–663
Benson H (1974) Permeability of the cornea to topically applied drugs. Arch Ophthalmol 91:313–327
Diestelhorst M, Aspacher F, Konen W, Krieglstein GK (1991) The effect of the flurbiprofen 0.03% eye drops on the blood-aqueous barrier in extracapsular cataract extraction with IOL implantation. Int Ophthalmol 15:69–73
Diestelhorst M, Aspacher F, Konen W, Krieglstein GK (1992) The comparative effect of fluorometholone 0.1 % and prednisolone-acetate 1.0% eye drops on the blood-aqueous barrier following cataract extraction and posterior chamber lense implantation. Eur J Implant Refract Surg (in press)
Flint GR (1984) Effect of derivatization of the bioavailability of ophthalmic steroids. Arch Ophthalmol 102:1808–1809
Kitzawa Y (1976) Increased intraocular pressure induced by corticosteroids. Am J Ophthalmol 82:492–495
Kupfermann A, Leibowitz HM (1980) Anti-inflammatory medications. Int Ophthalmol Clin 20:117–134
McGhee CNJ, Watson DG, Midgley JM, Noble MJ, Dutton GN, Fern AI (1990) Penetration of synthetic corticosteroids into human aqueous humor. Eye 4:526–530
Nelson EL (1970) Ophthalmic steroids. In: Kaufman HE (ed) Symposium on ocular anti-inflammatory therapy. Thomas, Springfield, pp 217–233
Polansky JR, Weinreb RN (1984) Steroids as anti-inflammatory agents. In: Sears ML (ed) Pharmacology of the eye. Springer, Berlin Heidelberg New York, pp 460–538
Rubin B, Palestine AG (1989) Complications of corticosteroid and immunsuppressive drugs. Int Ophthalmol Clin 29:159–171
Sanders DR, Kraff M (1984) Steroidal and nonsteroidal anti-inflammatory agents: effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol 102:1453–1456
Schlagel CA (1965) Comparative efficiacy of topical anti-inflammatory corticosteroids. J Pharm Sci 54:335–352
Shell JW (1982) Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 26:207–218
Watson D, Noble MJ, Dutton GN, Midgley JM, Healey TM (1988) Penetration of topically applied dexamethasone alcohol into human aqueous humor. Arch Ophthalmol 106:686–687
Author information
Authors and Affiliations
Additional information
Correspondence to: M. Diestelhorst
Rights and permissions
About this article
Cite this article
Diestelhorst, M., Aspacher, F., Konen, W. et al. Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric study. Graefe's Arch Clin Exp Ophthalmol 230, 451–453 (1992). https://doi.org/10.1007/BF00175932
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00175932